v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net income $ 2,474 $ 2,232
Adjustments to net income:    
Depreciation 884 709
Amortization of capitalized software 41 34
Stock compensation 245 222
Gains on sales of assets 0 (126)
Deferred taxes (137) (156)
Increase (decrease) from changes in:    
Accounts receivable (215) 76
Inventories (285) (107)
Prepaid expenses and other current assets (16) (46)
Accounts payable and accrued expenses (29) 25
Accrued compensation (255) (276)
Income taxes payable 61 332
Changes in funded status of retirement plans (27) 26
Other (32) (357)
Cash flows from operating activities 2,709 2,588
Cash flows from investing activities    
Capital expenditures (2,428) (2,312)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives 260 0
Proceeds from asset sales 0 194
Purchases of short-term investments (1,839) (6,962)
Proceeds from short-term investments 3,938 5,761
Other (13) (10)
Cash flows from investing activities (82) (3,329)
Cash flows from financing activities    
Proceeds from issuance of long-term debt 1,199 2,980
Repayment of debt (750) (300)
Dividends paid (2,473) (2,368)
Stock repurchases (955) (74)
Proceeds from common stock transactions 233 313
Other (37) (34)
Cash flows from financing activities (2,783) 517
Net change in cash and cash equivalents (156) (224)
Cash and cash equivalents at beginning of period 3,200 2,964
Cash and cash equivalents at end of period 3,044 2,740
Supplemental cash flow information    
Investment tax credit (ITC) used to reduce income taxes payable 203 312
Proceeds from CHIPS Act incentives 260 0
Total cash benefit related to the CHIPS Act $ 463 $ 312